Advanced prostate adenocarcinomas enriched in stem-cell features, as well as variant androgen receptor (AR)-negative neuroendocrine (NE)/small-cell prostate cancers are difficult to treat, and account for up to 30% of prostate cancer-related deaths …
(Visited 4 times, 1 visits today)
){kind=link}
Comments
Comments are disabled for this post.